- 专利标题: HISTONE DEMETHYLASE INHIBITORS
-
申请号: US16024452申请日: 2018-06-29
-
公开(公告)号: US20180305336A1公开(公告)日: 2018-10-25
- 发明人: Toufike Kanouni , Jeffrey Alan Stafford , James Marvin Veal , Michael Brennan Wallace
- 申请人: CELGENE QUANTICEL RESEARCH, INC.
- 申请人地址: US CA San Diego
- 专利权人: CELGENE QUANTICEL RESEARCH, INC.
- 当前专利权人: CELGENE QUANTICEL RESEARCH, INC.
- 当前专利权人地址: US CA San Diego
- 主分类号: C07D401/12
- IPC分类号: C07D401/12 ; C07D413/14 ; C07D471/04 ; C07D403/12 ; C07D401/14 ; C07D413/12 ; C07D405/14
摘要:
The present invention relates generally to compositions and methods for treating cancer and neoplastic disease. Provided herein are substituted 3-aminopyridine derivative compounds, substituted 3-aminopyridazine derivative compounds, and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.
公开/授权文献
- US10336727B2 Histone demethylase inhibitors 公开/授权日:2019-07-02
信息查询